Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pinsky

Showing results (291-300 of 328) with videos related to

Pageof 33
Sort By:
Nature Communications|August 3, 2022
An intranasal ASO therapeutic targeting SARS-CoV-2Chi Zhu, Justin Y Lee, Jia Z Woo, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variantVenkata-Viswanadh Edara, Lilin Lai, Malaya K Sahoo, et al.
Genome Medicine|March 29, 2022
An 8-gene machine learning model improves clinical prediction of severe dengue progressionYiran E Liu, Sirle Saul, Aditya Manohar Rao, et al.
Nature Communications|March 31, 2021
Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trialPrasanna Jagannathan, Jason R Andrews, Hector Bonilla, et al.
Science Advances|March 24, 2023
Magnitude and kinetics of the human immune cell response associated with severe dengue progression by single-cell proteomicsMakeda L Robinson, David R Glass, Veronica Duran, et al.
NPJ Vaccines|November 22, 2023
BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 variants in patients with lung cancerRajesh M Valanparambil, Lilin Lai, Margaret A Johns, et al.
The Lancet. Infectious Diseases|February 3, 2025
The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variantMehul S Suthar, Kelly E Manning, Madison L Ellis, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2020
Human B cell clonal expansion and convergent antibody responses to SARS-CoV-2Sandra C A Nielsen, Fan Yang, Katherine J L Jackson, et al.
Nature Immunology|October 23, 2023
Global and cell type-specific immunological hallmarks of severe dengue progression identified via a systems immunology approachLuca Ghita, Zhiyuan Yao, Yike Xie, et al.
Ebiomedicine|April 29, 2021
Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case seriesThao T Truong, Alex Ryutov, Utsav Pandey, et al.
Pageof 33

Showing results (291-300 of 328) with videos related to

Sort By:
Pageof 33
Nature Communications|August 3, 2022
An intranasal ASO therapeutic targeting SARS-CoV-2Chi Zhu, Justin Y Lee, Jia Z Woo, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variantVenkata-Viswanadh Edara, Lilin Lai, Malaya K Sahoo, et al.
Genome Medicine|March 29, 2022
An 8-gene machine learning model improves clinical prediction of severe dengue progressionYiran E Liu, Sirle Saul, Aditya Manohar Rao, et al.
Nature Communications|March 31, 2021
Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trialPrasanna Jagannathan, Jason R Andrews, Hector Bonilla, et al.
Science Advances|March 24, 2023
Magnitude and kinetics of the human immune cell response associated with severe dengue progression by single-cell proteomicsMakeda L Robinson, David R Glass, Veronica Duran, et al.
NPJ Vaccines|November 22, 2023
BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 variants in patients with lung cancerRajesh M Valanparambil, Lilin Lai, Margaret A Johns, et al.
The Lancet. Infectious Diseases|February 3, 2025
The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variantMehul S Suthar, Kelly E Manning, Madison L Ellis, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2020
Human B cell clonal expansion and convergent antibody responses to SARS-CoV-2Sandra C A Nielsen, Fan Yang, Katherine J L Jackson, et al.
Nature Immunology|October 23, 2023
Global and cell type-specific immunological hallmarks of severe dengue progression identified via a systems immunology approachLuca Ghita, Zhiyuan Yao, Yike Xie, et al.
Ebiomedicine|April 29, 2021
Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case seriesThao T Truong, Alex Ryutov, Utsav Pandey, et al.
Pageof 33